Table 2.
Medical findings (≥5%) in the first and second eyes at 3 months
| Adverse events | First eyes, n (%) | Second eyes, n (%) | ||
| ZFR00V IOL (n = 95) | TFNT00 IOL (n = 52) | ZFR00V IOL (n = 95) | TFNT00 IOL (n = 52) | |
| Blepharitis/meibomianitis | 7 (7.4) | 6 (11.5) | 6 (6.3) | 6 (11.5) |
| Dry eye/SPK/epithelial erosion/tear film insufficiency | 8 (8.4) | 4 (7.7) | 8 (8.4) | 4 (7.7) |
| PCO | 24 (25.3) | 10 (19.2) | 23 (24.2) | 9 (17.3) |
| Trace | 20 (21.1) | 6 (11.5) | 20 (21.1) | 7 (13.5) |
| Mild | 3 (3.2) | 3 (5.8) | 2 (2.1) | 1 (1.9) |
| Moderate | 1 (1.1) | 1 (1.9) | 1 (1.1) | 1 (1.9) |
| PC striae/wrinkles | 5 (5.3) | 5 (9.6) | 5 (5.3) | 4 (7.7) |
| Trace | 4 (4.2) | 3 (5.8) | 5 (5.3) | 3 (5.8) |
| Mild | 1 (1.1) | 1 (1.9) | 0 (0) | 0 (0) |
| Moderate | 0 (0) | 1 (1.9) | 0 (0) | 1 (1.9) |
| PVD/floaters | 4 (4.2) | 4 (7.7) | 3 (3.2) | 3 (5.8) |
| RPE changes | 2 (2.1) | 3 (5.8) | 2 (2.1) | 1 (1.9) |
PC = posterior capsular; PCO = posterior capsular opacification; PVD = posterior vitreous detachment; RPE = retinal pigment epithelium; SPK = superficial punctate keratopathy